0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

True Leukonychia in Crohn Disease Induced by Selenium Deficiency FREE

Naoko Hasunuma, MD, PhD1,2; Yoshihiro Umebayashi, MD, PhD2; Motomu Manabe, MD, PhD2
[+] Author Affiliations
1Department of Community Medicine and Primary Care Development, Akita University School of Medicine, Akita, Japan
2Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, Japan
JAMA Dermatol. 2014;150(7):779-780. doi:10.1001/jamadermatol.2013.6701.
Text Size: A A A
Published online

Leukonychia is divided into 2 major types: true leukonychia, which involves the nail plate, and apparent leukonychia, which involves the nail bed.1 Herein, we present the first case to our knowledge of true leukonychia successfully treated with selenium substitution.

REPORT OF A CASE

A man in his 30s presented with an 18-year history of Crohn disease and had undergone partial resections of both small and large bowel 6 times. In recent years, the patient had been maintained on total parenteral nutrition, taking enteral nutritional products because of short-bowel syndrome. He was referred to our outpatient clinic with a 2-week history of nail color changes.

On physical examination, we found that the proximal halves of the affected nails of his fingers and toes were whitish; the distal halves were normal; and the 2 color zones were sharply demarcated (Figure, A). Routine laboratory examination for patients on total parenteral nutrition revealed a significantly low serum selenium level (2.0 μg/dL; reference level, 10.6-17.4 μg/dL). After treatment with 100 μg/d of selenium for 8 weeks to improve the selenium deficiency, interestingly, the proximal part of the nails at the nail base gradually turned normal, and the whitish part moved toward the distal direction without changing in appearance or size (Figure, B). Consequently, the whitish part regressed completely, and the nail conditions turned normal in 14 weeks (Figure, C).

Place holder to copy figure label and caption
Figure.
Clinical Photographs of the Affected Patient

A, Leukonychia before selenium substitution manifests as whitish proximal fingernail halves, while the distal halves are normal, and on each nail, the 2 color zones are sharply demarcated. B, After 8 weeks of selenium substitution, the whitish halves of the fingernails have moved toward the distal portions. C, After 14 weeks of selenium substitution, the nail conditions have turned normal.

Graphic Jump Location

DISCUSSION

The present patient presented with true leukonychia in association with Crohn disease as well as selenium deficiency. Although there have been some reports about associations of leukonychia, Crohn disease, and selenium deficiency, all 3 conditions have not been discussed together. An association of Crohn disease with half-and-half nails has been reported in at least 1 case,2 but the serum selenium levels were not estimated in that case. Furthermore, Crohn disease has been associated with selenium deficiency,3 but the nail conditions were not described in detail in those reports. Therefore, we believe this case to be the first providing evidence that true leukonychia is caused in part, if not wholly, by selenium deficiency in Crohn disease and is curable with selenium substitution. However, care must be taken with adverse effects,4 and selenium levels must be carefully monitored to avoid toxic effects.

Leukonychia is caused by the abnormality of either nail bed or nail plate. In half-and-half nails, Lindsay5 has suggested that the whitish part of the nails stayed at the same portion and remained unchanged while the nail grew toward the distal portion, implying that the cause of color change begins in the nail bed rather than the nail plate. On the other hand, our true leukonychia case showed an interesting clinical course during the improvement of nail color in which the whitish part moved toward the distal portion during the nail growth after selenium substitution, suggesting that the primary pathologic site was not in the nail bed but in the nail plate.

In addition, little is known about specific physiological roles of selenium in the formation and/or maintenance of the nail apparatus. Selenium is a component of the antioxidant enzymes such as glutathione peroxidase and thioredoxin reductase as well as 3 deiodinase enzymes, which convert one thyroid hormone to another. Accordingly, it would be interesting to identify the level of selenium inside the nail matrix and to check also the thyroid profile and the activity of the antioxidant enzymes before and after the selenium substitution.6 Further study is needed to elucidate the pathogenic mechanisms of leukonychia due to deficiency of selenium.

ARTICLE INFORMATION

Corresponding Author: Naoko Hasunuma, MD, PhD, Department of Community Medicine and Primary Care Development, Akita University School of Medicine, Hondo1-1-1, Akita, Akita, 010-8543 Japan (matsunao@med.akita-u.ac.jp).

Published Online: March 26, 2014. doi:10.1001/jamadermatol.2013.6701.

Conflict of Interest Disclosures: None reported.

REFERENCES

Grossman  M, Scher  RK.  Leukonychia. Review and classification. Int J Dermatol. 1990;29(8):535-541.
PubMed   |  Link to Article
Pellegrino  M, Taddeucci  P, Mei  S, Peccianti  C, Fimiani  M.  Half-and-half nail in a patient with Crohn disease. J Eur Acad Dermatol Venereol. 2010;24(11):1366-1367.
PubMed   |  Link to Article
Hinks  LJ, Inwards  KD, Lloyd  B, Clayton  B.  Reduced concentrations of selenium in mild Crohn disease. J Clin Pathol. 1988;41(2):198-201.
PubMed   |  Link to Article
Lopez  RE, Knable  AL  Jr, Burruss  JB.  Ingestion of a dietary supplement resulting in selenium toxicity. J Am Acad Dermatol. 2010;63(1):168-169.
PubMed   |  Link to Article
Lindsay  PG.  The half-and-half nail. Arch Intern Med. 1967;119(6):583-587.
PubMed   |  Link to Article
Kieliszek  M, Błażejak  S.  Selenium: Significance, and outlook for supplementation. Nutrition. 2013;29(5):713-718.
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure.
Clinical Photographs of the Affected Patient

A, Leukonychia before selenium substitution manifests as whitish proximal fingernail halves, while the distal halves are normal, and on each nail, the 2 color zones are sharply demarcated. B, After 8 weeks of selenium substitution, the whitish halves of the fingernails have moved toward the distal portions. C, After 14 weeks of selenium substitution, the nail conditions have turned normal.

Graphic Jump Location

Tables

References

Grossman  M, Scher  RK.  Leukonychia. Review and classification. Int J Dermatol. 1990;29(8):535-541.
PubMed   |  Link to Article
Pellegrino  M, Taddeucci  P, Mei  S, Peccianti  C, Fimiani  M.  Half-and-half nail in a patient with Crohn disease. J Eur Acad Dermatol Venereol. 2010;24(11):1366-1367.
PubMed   |  Link to Article
Hinks  LJ, Inwards  KD, Lloyd  B, Clayton  B.  Reduced concentrations of selenium in mild Crohn disease. J Clin Pathol. 1988;41(2):198-201.
PubMed   |  Link to Article
Lopez  RE, Knable  AL  Jr, Burruss  JB.  Ingestion of a dietary supplement resulting in selenium toxicity. J Am Acad Dermatol. 2010;63(1):168-169.
PubMed   |  Link to Article
Lindsay  PG.  The half-and-half nail. Arch Intern Med. 1967;119(6):583-587.
PubMed   |  Link to Article
Kieliszek  M, Błażejak  S.  Selenium: Significance, and outlook for supplementation. Nutrition. 2013;29(5):713-718.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

402 Views
0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
×